High risk of cardiovascular disease in iron overload patients

作者: Tomás Meroño , Leonardo Gómez Rosso , Patricia Sorroche , Laura Boero , Jorge Arbelbide

DOI: 10.1111/J.1365-2362.2010.02429.X

关键词:

摘要: Eur J Clin Invest 2011; 41 (5): 479–486 Abstract Introduction  Iron overload (IO) is defined as an increase in storage iron, regardless of the presence or absence tissue damage. Whether increased iron stores are involved pathogenesis cardiovascular disease remains controversial. Objectives  To study insulin resistance markers, lipoprotein profile, activities anti and prooxidant enzymes cholesteryl ester transfer protein (CETP) patients with IO. Methods  Twenty male IO were compared 20 sex- age-matched controls. General biochemical parameters, paraoxonase 1, employing two substrates, paraoxon (PON) phenylacetate (ARE), lipoprotein-associated phospholipase A2 (Lp-PLA2) CETP determined. Results  showed higher levels HOMA-IR triglycerides [median (Q1–Q3)] [128 (93–193) vs. 79(51–91) mg dL−1, P < 0·0005] while lower high-density (HDL) cholesterol (mean ± SD) (41 ± 9 52 ± 10 mg dL−1, P < 0·0005) comparison Moreover, triglycerides/HDL-cholesterol [3·2 (2·0–5·1) 1·5 (1·0–1·9), ratio oxidized low-density [94 (64–103) 68 (59–70) IU L−1, P < 0·05] patient group. Although no difference was observed ARE activity, PON activity decreased [246 (127–410) 428 (263–516) nmol mL−1 min−1, P < 0·05]. In addition, Lp-PLA2 also (189 ± 31 155 ± 36% ml−1 h−1, P < 0·005; 10·1 ± 2·9 8·2 ± 2·4 μmol mL−1 h−1, P < 0·05, respectively). Associations between ferritin concentration alterations lipid metabolism found. Multiple regression analyses identified independent predictor (B = 65·9, P < 0·0001, r2 = 0·35), well (B = 3·7, r2 = 0·40) after adjusting for confounding variables. Conclusions  presented not only but metabolic that related to elevated associated high risk disease.

参考文章(45)
Jakub J. Regieli, J. Wouter Jukema, Pieter A. Doevendans, Aeilko H. Zwinderman, John J. Kastelein, Diederick E. Grobbee, Yolanda van der Graaf, Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease Journal of the American College of Cardiology. ,vol. 54, pp. 1238- 1245 ,(2009) , 10.1016/J.JACC.2009.05.061
B N La Du, C M Wyte, H W Eckerson, The human serum paraoxonase/arylesterase polymorphism. American Journal of Human Genetics. ,vol. 35, pp. 1126- 1138 ,(1983)
D. A. McClain, D. Abraham, J. Rogers, R. Brady, P. Gault, R. Ajioka, J. P. Kushner, High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis Diabetologia. ,vol. 49, pp. 1661- 1669 ,(2006) , 10.1007/S00125-006-0200-0
Hannes Gaenzer, Peter Marschang, Wolfgang Sturm, G ünther Neumayr, Wolfgang Vogel, Josef Patsch, G ünter Weiss, None, Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis Journal of the American College of Cardiology. ,vol. 40, pp. 2189- 2194 ,(2002) , 10.1016/S0735-1097(02)02611-6
Merle L. Blank, Marvin N. Hall, Edgar A. Cress, Fred Snyder, Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochemical and Biophysical Research Communications. ,vol. 113, pp. 666- 671 ,(1983) , 10.1016/0006-291X(83)91778-3
JeromeL. Sullivan, IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK The Lancet. ,vol. 317, pp. 1293- 1294 ,(1981) , 10.1016/S0140-6736(81)92463-6
Tomi-Pekka Tuomainen, Ulf Diczfalusy, Jari Kaikkonen, Kristiina Nyyssönen, Jukka T Salonen, Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man Free Radical Biology and Medicine. ,vol. 35, pp. 922- 928 ,(2003) , 10.1016/S0891-5849(03)00433-7
Joan Carles Escolà-Gil, Noemí Rotllan, Josep Julve, Francisco Blanco-Vaca, In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection. Atherosclerosis. ,vol. 206, pp. 321- 327 ,(2009) , 10.1016/J.ATHEROSCLEROSIS.2008.12.044
V.K. Lee, D.B. Loeb, F.A. Mapa, E. McClelland, N.C. Meyer, G.A. Mintier, N. Moeller, T. Moore, E. Morikang, C.E. Prass, L. Quintana, S.M. Starnes, R.C. Schatzman, K.J. Brunke, D.T. Drayna, N.J. Risch, B.R. Bacon, R.K. Wolff, J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, A. Basava, F. Dormishian, R. Domingo, M.C. Ellis, A. Fullan, L.M. Hinton, N.L. Jones, B.E. Kimmel, G.S. Kronmal, P. Lauer, A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis Nature Genetics. ,vol. 13, pp. 399- 408 ,(1996) , 10.1038/NG0896-399